Anika Therapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan '26 Jan 30, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	112	233	300	405	455	526
Market Cap Growth	-50.87%	-22.42%	-25.82%	-11.04%	-13.52%	-20.23%
Enterprise Value	84	199	263	352	393	463
Last Close Price	7.00	15.50	20.40	27.40	32.40	34.80
PE Ratio	-	-	-	-	125.13	-
PS Ratio	1.17	2.01	2.75	3.80	3.50	4.93
PB Ratio	0.90	1.57	1.56	1.51	1.80	2.36
P/TBV Ratio	0.96	1.67	1.64	2.12	2.63	3.72
P/FCF Ratio	202.86	-	-	-	158.96	56.25
P/OCF Ratio	16.16	44.62	-	98.08	61.60	49.24
EV/Sales Ratio	0.88	1.72	2.40	3.30	3.03	4.34
EV/EBITDA Ratio	-	56.88	18.37	20.70	194.39	151.74
EV/EBIT Ratio	-	-	182.42	102.39	-	-
EV/FCF Ratio	151.83	-	-	-	137.51	49.55
Debt / Equity Ratio	0.17	0.17	0.13	0.11	0.07	0.08
Debt / EBITDA Ratio	108.08	3.48	1.42	1.44	4.12	3.52
Debt / FCF Ratio	37.82	-	-	-	6.44	1.96
Asset Turnover	0.54	0.51	0.39	0.33	0.41	0.38
Inventory Turnover	1.80	1.80	1.17	1.07	1.42	1.80
Quick Ratio	4.20	3.40	3.06	4.33	4.17	3.32
Current Ratio	5.32	4.88	5.26	6.07	5.66	4.81
Return on Equity (ROE)	-8.73%	-4.82%	-1.38%	0.77%	1.48%	-8.55%
Return on Assets (ROA)	-3.50%	-1.19%	0.32%	0.66%	-2.11%	-1.75%
Return on Invested Capital (ROIC)	-10.13%	-3.04%	-0.86%	0.84%	-5.86%	-6.03%
Return on Capital Employed (ROCE)	-6.90%	-2.50%	0.70%	1.10%	-3.80%	-3.00%
Earnings Yield	-25.13%	-23.39%	-24.92%	-3.44%	0.80%	-3.73%
FCF Yield	0.49%	-0.97%	-2.17%	-0.71%	0.63%	1.78%
Buyback Yield / Dilution	2.20%	-0.44%	-0.65%	0.50%	-2.90%	1.06%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.